🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the efficacy, safety and tolerability of Remibrutinib v...
Status
Recruiting
Location
Neuromuscular Research Center
Start Date
2025-02-07
Trial ID
NCT06744920
Treatments Being Tested
The purpose of this study was to establish the efficacy, safety, and tolera...
Status
Completed
Location
Cahaba Derm and skin hlth ctr 27
Start Date
2021-12-01
Trial ID
NCT05032157
Treatments Being Tested
This was a proof-of-concept study to evaluate the efficacy of LOU064 in pat...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-18
Trial ID
NCT03944707
Treatments Being Tested
The purpose of this study is to explore the effect and Mechanism of Action ...
Status
Recruiting
Location
Ziaderm Research LLC
Start Date
2025-05-22
Trial ID
NCT06865651
Treatments Being Tested
A study to evaluate the safety, efficacy and tolerability of remibrutinib a...
Status
Completed
Location
Allervie Clinical Research
Start Date
2022-10-12
Trial ID
NCT05432388
The purpose of this trial is: 1. to assess the efficacy, pharmacokinetics,...
Status
Active Not Recruiting
Location
Kern Research
Start Date
2023-07-11
Trial ID
NCT05677451
Treatments Being Tested
The main purpose of this study is to assess preliminary efficacy and safety...
Status
Active Not Recruiting
Location
Olympian Clinical Research
Start Date
2019-02-27
Trial ID
NCT03827798
The purpose of this study is to provide efficacy and safety data for remibr...
Status
Recruiting
Location
Alabama Neurology Associates PC
Start Date
2025-11-11
Trial ID
NCT07225504
Treatments Being Tested
The purpose of this extension study is to collect long-term efficacy, safet...
Status
Active Not Recruiting
Location
Allervie Clinical Research
Start Date
2022-12-09
Trial ID
NCT05513001
Treatments Being Tested